Unlocking the value of data in decentralised clinical trials

Simon Tilley, SAS, breaks down the benefits and drawbacks of decentralised clinical trials (DCT). He also explains how AI, machine learning and advanced analytics can refine all stages from participant recruitment to compiling results.